Prebiotic effect of xylooligosaccharides produced from birchwood xylan by a novel fungal GH11 xylanase

Food Chemistry

Volumn 232, Issue , 2017, Pages 105-113

  Nieto Domínguez, Manuel ^a   de Eugenio, Laura I ^a   York Durán, María J ^b   Rodríguez Colinas, Barbara ^b   Plou, Francisco J ^b   Chenoll, Empar ^c   Pardo, Ester ^c   Codoñer, Francisco ^c   Jesús Martínez, María ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b INSTITUTO DE CATÁLISIS Y PETROLEOQUÍMICA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Breast fed; Microbiome; SCFAs; Staphylococcus hominis; XOS; Xylosidase

Indexed keywords

ENZYMES; LACTIC ACID; MIXTURES;

BREAST-FED; MICROBIOME; SCFAS; STAPHYLOCOCCUS HOMINIS; XYLOSIDASE;

BACTERIA;

CARBOXYMETHYLCELLULOSE; CELLOBIOSE; CELLULASE; FUNGAL ENZYME; GLUCOSE; MICROCRYSTALLINE CELLULOSE; OLIGOSACCHARIDE; PREBIOTIC AGENT; UNCLASSIFIED DRUG; XYLAN; XYLAN ENDO 1,3 BETA XYLOSIDASE; XYLOOLIGOSACCHARIDE; ENDO 1,4 BETA XYLANASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; ENZYME ISOLATION; ENZYME PURIFICATION; HYDROLYSIS; MICHAELIS MENTEN KINETICS; MICROBIAL COMMUNITY; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; REACTION TIME; STAPHYLOCOCCUS HOMINIS; STOP CODON; TALAROMYCES; TALAROMYCES AMESTOLKIAE; BIFIDOBACTERIUM;

BIFIDOBACTERIUM; ENDO-1,4-BETA XYLANASES; HYDROLYSIS; OLIGOSACCHARIDES; PREBIOTICS; TALAROMYCES; XYLANS;

EID: 85017149952     PISSN: 03088146     EISSN: 18737072     Source Type: Journal    
DOI: 10.1016/j.foodchem.2017.03.149     Document Type: Article

References (40)

1. Aachary, A.A., Prapulla, S.G., Value addition to corncob: Production and characterization of xylooligosaccharides from alkali pretreated lignin-saccharide complex using Aspergillus oryzae MTCC 5154. Bioresource Technology 100 (2009), 991–995.
2. Aachary, A.A., Prapulla, S.G., Xylooligosaccharides (XOS) as an emerging prebiotic: Microbial synthesis, utilization, structural characterization, bioactive properties, and applications. Comprehensive Reviews in Food Science and Food Safety 10 (2011), 2–16.
3. Ahn, Y.H., Yoo, J.S., Piperidine as an efficient organic catalyst of derivatization of oligosaccharides with malononitrile for high-sensitivity electrospray ionization mass analysis. Analytical Sciences 17 (2001), 893–895.
4. Akpinar, O., Erdogan, K., Bakir, U., Yilmaz, L., Comparison of acid and enzymatic hydrolysis of tobacco stalk xylan for preparation of xylooligosaccharides. LWT-Food Science and Technology 43 (2010), 119–125.
5. Barile, D., Rastall, R.A., Human milk and related oligosaccharides as prebiotics. Current Opinion in Biotechnology 24 (2013), 214–219.
6. Belancic, A., Scarpa, J., Peirano, A., Diaz, R., Steiner, J., Eyzaguirre, J., Penicillium purpurogenum produces several xylanases. Purification and properties of two of the enzymes. Journal of Biotechnology 41 (1995), 71–79.
7. Bian, J., Peng, F., Peng, X.P., Peng, P., Xu, F., Sun, R.C., Structural features and antioxidant activity of xylooligosaccharides enzymatically produced from sugarcane bagasse. Bioresource Technology 127 (2013), 236–241.
8. Bin, Y., Hongzhang, C., Effect of the ash on enzymatic hydrolysis of steam-exploded rice straw. Bioresource Technology 101 (2010), 9114–9119.
9. Burton, J.P., Chilcott, C.N., Moore, C.J., Speiser, G., Tagg, J.R., A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. Journal of Applied Microbiology 100 (2006), 754–764.
10. Chapla, D., Pandit, P., Shah, A., Production of xylooligosaccharides from corncob xylan by fungal xylanase and their utilization by probiotics. Bioresource Technology 115 (2012), 215–221.
11. Chavez, R., Bull, P., Eyzaguirre, J., The xylanolytic enzyme system from the genus Penicillium. Journal of Biotechnology 123 (2006), 413–433.
12. Fooks, L.J., Fuller, R., Gibson, G.R., Prebiotics, probiotics and human gut microbiology. International Dairy Journal 9 (1999), 53–61.
13. Gibson, G.R., Probert, H.M., Van Loo, J., Rastall, R.A., Roberfroid, M.B., Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutrition Research Reviews 17 (2004), 259–275.
14. Julak, J., Stránská, E., Procházková-Francisci, E., Rosová, V., Blood cultures evaluation by gas chromatography of volatile fatty acids. Medical Science Monitor 6 (2000), 605–610.
15. Kabel, M.A., Kortenoeven, L., Schols, H.A., Voragen, A.G.J., In vitro fermentability of differently substituted xylo-oligosaccharides. Journal of Agricultural and Food Chemistry 50 (2002), 6205–6210.
16. Klindworth, A., Pruesse, E., Schweer, T., Peplies, J., Quast, C., Horn, M., et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Research, 41, 2013.
17. Kloos, W.E., Schleifer, K.H., Isolation and characterization of staphylococci from human skin II. Descriptions of four new species: Staphylococcus warneri, Staphylococcus capitis, Staphylococcus hominis, and Staphylococcus simulans. International Journal of Systematic Bacteriology 25 (1975), 62–79.
18. Laemmli, U.K., Cleavage of structural proteins during assembly of head of bacteriophage-T4. Nature 227 (1970), 680–685.
19. Lecerf, J.M., Depeint, F., Clerc, E., Dugenet, Y., Niamba, C.N., Rhazi, L., et al. Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. British Journal of Nutrition 108 (2012), 1847–1858.
20. Li, Z., Summanen, P.H., Komoriya, T., Finegold, S.M., In vitro study of the prebiotic xylooligosaccharide (XOS) on the growth of Bifidobacterium spp and Lactobacillus spp. International Journal of Food Sciences and Nutrition 66 (2015), 919–922.
21. Linares-Pastén, J.A., Karlsson, E.N., Aronsson, A., Structural considerations on the use of endo-xylanases for the production of prebiotic xylooligosaccharides from biomass. Current Protein & Peptide Science 17 (2016), 1–20.
22. Lopez-Brea, M., Alarcon, T., Domingo, D., Diaz-Reganon, J., Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates. Journal of Antimicrobial Chemotherapy 61 (2008), 139–142.
23. Macfarlane, G.T., Macfarlane, S., Gibson, G.R., Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microbial Ecology 35 (1998), 180–187.
24. Macfarlane, S., Macfarlane, G.T., Cummings, J.H., Review article: Prebiotics in the gastrointestinal tract. Alimentary Pharmacology & Therapeutics 24 (2006), 701–714.
25. Marcobal, A., Barboza, M., Froehlich, J.W., Block, D.E., German, J.B., Lebrilla, C.B., et al. Consumption of human milk oligosaccharides by gut-related microbes. Journal of Agricultural and Food Chemistry 58 (2010), 5334–5340.
26. Martin, R., Heilig, H.G.H.J., Zoetendal, E.G., Jimenez, E., Fernandez, L., Smidt, H., et al. Cultivation-independent assessment of the bacterial diversity of breast milk among healthy women. Research in Microbiology 158 (2007), 31–37.
27. Nelson, N., A photometric adaptation of the Somogyi method for the determination of glucose. Journal of Biological Chemistry 153 (1944), 375–380.
28. Newburg, D.S., Walker, W.A., Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatric Research 61 (2007), 2–8.
29. Nieto-Dominguez, M., de Eugenio, L.I., Barriuso, J., Prieto, A., Fernandez de Toro, B., Canales-Mayordomo, A., et al. Novel pH-stable glycoside hydrolase family 3 β-xylosidase from Talaromyces amestolkiae: An enzyme displaying regioselective transxylosylation. Applied and Environmental Microbiology 81 (2015), 6380–6392.
30. Polizeli, M.L.T.M., Rizzatti, A.C.S., Monti, R., Terenzi, H.F., Jorge, J.A., Amorim, D.S., Xylanases from fungi: Properties and industrial applications. Applied Microbiology and Biotechnology 67 (2005), 577–591.
31. Pollet, A., Delcour, J.A., Courtin, C.M., Structural determinants of the substrate specificities of xylanases from different glycoside hydrolase families. Critical Reviews in Biotechnology 30 (2010), 176–191.
32. Rastall, R.A., Gibson, G.R., Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health. Current Opinion in Biotechnology 32 (2015), 42–46.
33. Rodriguez-Colinas, B., Kolida, S., Baran, M., Ballesteros, A.O., Rastall, R.A., Plou, F.J., Analysis of fermentation selectivity of purified galacto-oligosaccharides by in vitro human faecal fermentation. Applied Microbiology and Biotechnology 97 (2013), 5743–5752.
34. Ryan, S.E., Nolan, K., Thompson, R., Gubitz, G.M., Savage, A.V., Tuohy, M.G., Purification and characterization of a new low molecular weight endoxylanase from Penicillium capsulatum. Enzyme and Microbial Technology 33 (2003), 775–785.
35. Smedley, J.G., Fisher, D.J., Sayeed, S., Chakrabarti, G., McClane, B.A., The enteric toxins of Clostridium perfringens. Amara, S.G., Bamberg, E., Jahn, R., Lederer, W.J., Miyajima, A., Murer, H., Offermanns, S., Schultz, G., Schweiger, M., (eds.) Reviews of physiology, biochemistry and pharmacology, 2005, Springer-Verlag, Berlin, 183–204.
36. Smego, R.A., Foglia, G., Actinomycosis. Clinical Infectious Diseases 26 (1998), 1255–1261.
37. Sung, C., Kim, B., Kim, S., Joo, H., Kim, P.I., Probiotic potential of Staphylococcus hominis MBBL 2–9 as anti-Staphylococcus aureus agent isolated from the vaginal microbiota of a healthy woman. Journal of Applied Microbiology 108 (2010), 908–916.
38. Thomas, D.W., Greer, F.R., Clinical report-Probiotics and prebiotics in pediatrics. Pediatrics 126 (2010), 1217–1231.
39. Yin, Y., Mao, X., Yang, J., Chen, X., Mao, F., Xu, Y., DbCAN: A web resource for automated carbohydrate-active enzyme annotation. Nucleic Acids Research 40 (2012), W445–W451.
40. Yuan, S.Q., Cohen, D.B., Ravel, J., Abdo, Z., Forney, L.J., Evaluation of methods for the extraction and purification of DNA from the human microbiome. PLoS ONE, 7(3), 2012, e33865, 10.1371/journal.pone.0033865.